Codexis (CDXS) Cash & Current Investments (2010 - 2026)

Codexis' (CDXS) quarterly Cash & Current Investments came in at $65.1 million in Q1 2026, up 8.9% year-on-year from $59.8 million in Q1 2025, and down 16.71% quarter-over-quarter from $78.2 million in Q4 2025.

Codexis (CDXS) Cash & Current Investments (2010 - 2026) Analysis & Trends

Codexis' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $65.1 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 8.9% year-over-year to $65.1 million in Q1 2026; TTM through Mar 2026 was $65.1 million, a 8.9% increase from a year earlier, with the FY2025 full-year figure at $78.2 million, up 6.46% from the prior year.
  • Cash & Current Investments retreated to $65.1 million in Q1 2026 per CDXS's latest filing, from $78.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $114.0 million in Q4 2022 and bottomed at $2.1 million in Q1 2022.
  • The 5-year median for Cash & Current Investments is $66.3 million (2025), against an average of $70.0 million.
  • Biggest YoY gain for Cash & Current Investments was 5075.67% in 2022; the steepest drop was 98.51% in 2022.
  • Year by year, Cash & Current Investments stood at $114.0 million in 2022, then slumped by 42.87% to $65.1 million in 2023, then grew by 12.82% to $73.5 million in 2024, then grew by 6.46% to $78.2 million in 2025, then retreated by 16.71% to $65.1 million in 2026.
  • Per Business Quant, the three latest CDXS Cash & Current Investments figures stand at $65.1 million (Q1 2026), $78.2 million (Q4 2025), and $58.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,320.50 Bn 66,320.21 Bn - 283.54 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - 61.40 Mn
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.93 Bn 468.14 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.22 Bn 114.98 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.96 Bn 61.21 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.07 Bn 50.89 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.60 Bn 34.59 Bn 959.66 Mn 3.01 Bn
10 Codexis 140.24 Mn 75.10 Mn 13.18 Mn 65.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 65.14 Mn
Dec 31, 2025 78.21 Mn
Sep 30, 2025 58.75 Mn
Jun 30, 2025 66.33 Mn
Mar 31, 2025 59.82 Mn
Dec 31, 2024 73.46 Mn
Sep 30, 2024 54.38 Mn
Jun 30, 2024 56.18 Mn
Mar 31, 2024 29.08 Mn
Dec 31, 2023 65.12 Mn
Sep 30, 2023 74.58 Mn
Jun 30, 2023 92.09 Mn
Mar 31, 2023 102.83 Mn
Dec 31, 2022 113.98 Mn
Sep 30, 2022 108.69 Mn
Jun 30, 2022 90.11 Mn
Mar 31, 2022 2.09 Mn
Dec 31, 2021 116.80 Mn
Sep 30, 2021 2.10 Mn
Jun 30, 2021 2.10 Mn